Literature DB >> 19347389

First Irish birth following IVF therapy using antagonist protocol.

E V Mocanu1, N Kondaveeti, J Kelly, B Hennelly, L Burke, C Hughes.   

Abstract

BACKGROUND: During in vitro fertilization (IVF), the prevention of a premature LH surge was traditionally achieved using a gonadotrophin releasing hormone agonist (GnRH-a), and more recently, a GnRH antagonist. AIMS: We report a case of a 37 year old treated using the GnRH antagonist in a second completed cycle of IVF.
METHODS: IVF was performed for primary infertility of 5-year duration due to frozen pelvis secondary to endometriosis.
RESULTS: Following controlled ovarian hyperstimulation, oocyte recovery and fertilization, cleavage and transfer of two zygotes, a pregnancy established. A twin gestation was diagnosed at 7-weeks scan and pregnancy ended with the delivery of twin girls by emergency caesarean section.
CONCLUSION: This is a first report of a delivery following IVF using the antagonist protocol in Ireland. Such therapy is patient friendly and its use should be introduced on a larger scale in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347389     DOI: 10.1007/s11845-009-0336-2

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

1.  Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.

Authors:  C Albano; J Smitz; M Camus; H Riethmüller-Winzen; A Van Steirteghem; P Devroey
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

2.  Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.

Authors:  H S Qublan; Z Amarin; Y A Tahat; A Z Smadi; M Kilani
Journal:  Hum Reprod       Date:  2005-10-27       Impact factor: 6.918

3.  Short-term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization.

Authors:  K P Katayama; M Roesler; C Gunnarson; E Stehlik; S Jagusch
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-12

Review 4.  GnRH antagonists in ovarian stimulation for IVF.

Authors:  B C Tarlatzis; B C Fauser; E M Kolibianakis; K Diedrich; L Rombauts; P Devroey
Journal:  Hum Reprod Update       Date:  2006-03-27       Impact factor: 15.610

5.  Birth after the reimplantation of a human embryo.

Authors:  P C Steptoe; R G Edwards
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

Review 6.  Gonadotrophin-releasing hormone antagonists for assisted conception.

Authors:  H G Al-Inany; A M Abou-Setta; M Aboulghar
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol.

Authors:  Hesham Al-Inany; Mohamed A Aboulghar; Ragaa T Mansour; Gamal I Serour
Journal:  Reprod Biomed Online       Date:  2005-05       Impact factor: 3.828

8.  Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.

Authors:  Edgar Mocanu; Marie Louise Redmond; Bernadette Hennelly; Claire Collins; Robert Harrison
Journal:  Hum Fertil (Camb)       Date:  2007-09       Impact factor: 2.767

9.  Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).

Authors:  L R Nelson; V Y Fujimoto; R B Jaffe; S E Monroe
Journal:  Fertil Steril       Date:  1995-05       Impact factor: 7.329

10.  Premature luteinization of follicles during ovarian stimulation for in-vitro fertilization.

Authors:  M Hamori; J A Stuckensen; D Rumpf; T Kniewald; A Kniewald; C S Kurz
Journal:  Hum Reprod       Date:  1987-11       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.